戻る
Adial Pharmaceuticals Inc (ADIL)価格
ADIL 株価推移チャート
ADIL 収入
Adial Pharmaceuticals Inc
$0.22
-0.88%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.23
4.39%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.227
始値
$0.2245
当日レンジ
$0.222 - $0.2349
52週レンジ
$0.21 - $1.3
取引高
251.5K
平均取引高
384.4K
1株当たり利益(TTM)
-0.93
配当利回り
--
時価総額
$5.6M
ADILとは何ですか？
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. The company is headquartered in Charlottesville, Virginia and currently employs 5 full-time employees. The company went IPO on 2018-07-27. The firm is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.